Developing SBIR Commercialization Strategy for FemTech Start-up
Carolyn leveraged her background in tech commercialization to help Cervu Health stand out amongst competitors and receive a highly competition SBIR Phase I award from the NIH
Cervu is a universty start up stemming from the Research Triangle of North Carolina. The founders met at North Carolina State University and the University of North Carolina - Chapel Hill.
Client Overview
Cervu is a health care startup working to create pelvic floor physical therapy tool to help female cancer survivors and their physical therapist and doctors manage chronic pelvic pain and dyspareunia (pain with sexual intercourse).
Project Background and Scope
Female cancer survivors who suffer from adverse effects from chemotherapy, radiation, hormonal therapy, or surgeries. This may include conditions such as vaginal stenosis, vulvodynia, myofascial pain syndrome, pelvic floor muscle spasms, vaginismus, dyspareunia, or other chronic pelvic pain conditions.
The Cervu treatment system is a novel intravaginal device that will allow easy performance of multiple therapeutic modalities to treat numerous medical conditions. Currently under development, the device will seek to improve the treatment experience for women while allowing the supervising doctor or physical therapist to easily assess treatment progress and adjust the treatment plan.
Our Support
Carolyn has worked alongside Cervu as a market strategy consultant since 2021 and was brought on in 2023 as an SBIR Principal Investigator and intertim-COO to oversee the develop and commercialization of Cervu’s core product.
Results
Cervu received a highly competitive Phase I SBIR award from the NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development in the Fall of 2023 for the further testing and validation of the MVP. Cervu has additionally received grants and support from the North Carolina Translational and Clinical sciences Institute, the NC Biotech Center, Venturewell, and NC State’s E-games.